Spectral AI Inc
MDAI
Company Profile
Business description
Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient’s wound.
Contact
2515 McKinney Avenue
Suite 1000
DallasTX75201
USAT: +1 972 499-4934
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2025
Employees
78
Stocks News & Analysis
stocks
Investors overly negative on cheap ASX share
We cut our fair value by 26% but the market has overreacted.
stocks
Overvalued US AI play reports earnings
Strong earnings with high projected growth but price is too rich.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,918.30 | 4.70 | 0.05% |
| CAC 40 | 8,176.29 | 25.65 | 0.31% |
| DAX 40 | 24,299.24 | 99.74 | 0.41% |
| Dow JONES (US) | 48,237.13 | 285.28 | 0.59% |
| FTSE 100 | 9,901.47 | 63.70 | 0.65% |
| HKSE | 25,690.53 | 192.40 | 0.75% |
| NASDAQ | 23,246.47 | 240.11 | 1.04% |
| Nikkei 225 | 49,507.21 | 505.71 | 1.03% |
| NZX 50 Index | 13,333.40 | 76.63 | 0.58% |
| S&P 500 | 6,828.70 | 53.94 | 0.80% |
| S&P/ASX 200 | 8,621.40 | 0.10 | -0.00% |
| SSE Composite Index | 3,890.45 | 14.08 | 0.36% |